David Berlach, MD
Radiation Oncology · Brooklyn, NYNPI 1811275514
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Roche Molecular Systems, Inc. at 28.5% of the total.
Across 96 payments — averaging $62.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Molecular Systems, Inc.$2K
- Visionrt, Inc.$1K
- Siemens Medical Solutions USA, Inc.$569
- Johnson & Johnson$321
- Takeda Pharmaceuticals U.S.A., Inc.$245
- Merck$227
- plus $2K from 21 others
What the payments were for
- Consulting fees$85014%
- Speaking & faculty fees$85014%
- Travel & lodging$1,69929%
- Food & beverage$2,56043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Molecular Systems, Inc. | 2 | $1,700 |
| Visionrt, Inc. | 2 | $1,319 |
| Siemens Medical Solutions USA, Inc. | 4 | $569 |
| Johnson & Johnson | 11 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $245 |
| Merck | 10 | $227 |
| Novartis | 9 | $178 |
| Icotec Medical Inc. | 1 | $171 |
| Mevion_medical_systems_inc | 1 | $171 |
| Eisai Inc. | 6 | $132 |
| Bayer | 5 | $112 |
| Agios Pharmaceuticals, Inc. | 4 | $102 |
| AstraZeneca | 5 | $88 |
| Deciphera Pharmaceuticals Inc. | 3 | $82 |
| Genmab U.S., Inc. | 3 | $80 |
| Roche Diagnostics Corporation | 1 | $74 |
| Nuvation Bio Inc. | 2 | $58 |
| Puma Biotechnology, Inc. | 2 | $48 |
| Servier Pharmaceuticals LLC | 2 | $40 |
| Blueprint Medicines Corporation | 1 | $36 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Syndax Pharmaceuticals, Inc. | 2 | $33 |
| Karyopharm Therapeutics Inc. | 1 | $30 |
| Tactile Systems Technology Inc | 1 | $28 |
| Tesaro, Inc. | 1 | $28 |
| Gilead | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,959 in reported general payments places this provider in the 85th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Brooklyn
- Hani AshamallaBrooklyn$7K
- Thomas DanielsBrooklyn$4K
- Chung ChungSyracuse$3.1M
- Michael ZelefskyNew York$946K
- Jeffrey BogartSyracuse$772K
- Steven FinkelsteinSyracuse$578K
- Shawn ZimbergPlainview$411K
- Edward ObedianOyster Bay$391K
- Nancy LeeNew York$233K
- Dheerendra PrasadBuffalo$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.